New drug TNX-1500 tested in healthy people for first time
NCT ID NCT07473752
First seen Apr 07, 2026 · Last updated May 20, 2026 · Updated 6 times
Summary
This early-stage study tested the safety of a new drug called TNX-1500 in 26 healthy adults. Participants received either a single dose of the drug or a placebo, and researchers monitored side effects and how the drug moved through the body. The goal was not to treat any disease, but to gather important safety information before future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHASE 1 FIRST-IN-HUMAN STUDY INVOLVING HEALTHY SUBJECTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CTI Clinical Research Center
Cincinnati, Ohio, 45212, United States
Conditions
Explore the condition pages connected to this study.